Experimental Treatments for Terminal Illnesses
-
KY ST T. XVIII, Ch. 217, Experimental Treatments for Terminal Illnesses, Refs & Annos
-
217.5401 Definitions for KRS 217.5401 to 217.5408
-
217.5402 Manufacturer of Investigational Drug, Biological Product, or Device May Make IT Available to a Requesting Patient Eligible Under KRS 217.5401 to 217.5408
-
217.5403 Eligibility Requirements for Treatment with Investigational Drug, Biological Product, or Device
-
217.5404 Written, Informed Consent Required for Treatment with Investigational Drug, Biological Product, or Device
-
217.5405 Limitations on Impact KRS 217.5401 to 217.5408 May Have on Insurance Coverage or Health Facility Services; Coverage Permitted; Approval of Health Facility for Use
-
217.5406 Death of Patient Receiving Experimental Treatment Absolves Heirs of Liability for Resulting Debt
-
217.5407 Healthcare Provider Held Harmless for Recommendation that a Patient Have Access to Experimental Treatment
-
217.5408 Prohibition Against Blocking or Attempting to Block Access by Eligible Patient to Experimental Treatment
-
217.5409 Limitations on Impact KRS 217.5401 to 217.5415 May Have on Insurance Coverage or Health Facility Services; Coverage Permitted; Approval of Health Facility for Use—Renumbered